iRadimed Corporation (IRMD): Price and Financial Metrics


iRadimed Corporation (IRMD): $28.55

-0.23 (-0.80%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

IRMD POWR Grades

  • IRMD scores best on the Sentiment dimension, with a Sentiment rank ahead of 98.9% of US stocks.
  • IRMD's strongest trending metric is Growth; it's been moving down over the last 177 days.
  • IRMD ranks lowest in Momentum; there it ranks in the 1st percentile.

IRMD Stock Summary

  • Price to trailing twelve month operating cash flow for IRMD is currently 34.62, higher than 85.74% of US stocks with positive operating cash flow.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.15 for IRADIMED CORP; that's greater than it is for just 11.28% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, IRADIMED CORP is reporting a growth rate of 97.51%; that's higher than 85.44% of US stocks.
  • Stocks that are quantitatively similar to IRMD, based on their financial statements, market capitalization, and price volatility, are AVNS, ARTW, ISDR, POWL, and HAYN.
  • Visit IRMD's SEC page to see the company's official filings. To visit the company's web site, go to www.iradimed.com.

IRMD Valuation Summary

  • In comparison to the median Healthcare stock, IRMD's EV/EBIT ratio is 152.87% higher, now standing at 22.
  • IRMD's price/sales ratio has moved up 0.3 over the prior 102 months.

Below are key valuation metrics over time for IRMD.

Stock Date P/S P/B P/E EV/EBIT
IRMD 2022-12-02 7.4 5.4 28.7 22.0
IRMD 2022-12-01 7.5 5.4 29.1 22.4
IRMD 2022-11-30 7.4 5.3 28.5 21.8
IRMD 2022-11-29 7.1 5.1 27.2 20.7
IRMD 2022-11-28 7.1 5.1 27.3 20.7
IRMD 2022-11-25 7.1 5.1 27.5 20.9

IRMD Growth Metrics

    The 5 year net income to common stockholders growth rate now stands at 32.44%.
  • Its 2 year net cashflow from operations growth rate is now at 9.08%.
  • Its 5 year price growth rate is now at 137.78%.
Over the past 33 months, IRMD's revenue has gone up $11,795,270.

The table below shows IRMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 50.31241 10.36991 13.04754
2022-06-30 47.81244 9.80979 12.19669
2022-03-31 44.90129 11.74126 10.42534
2021-12-31 41.81458 11.25816 9.325471
2021-09-30 38.48776 10.38818 6.070218
2021-06-30 35.27956 8.344037 4.568603

IRMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IRMD has a Quality Grade of A, ranking ahead of 97.83% of graded US stocks.
  • IRMD's asset turnover comes in at 0.488 -- ranking 96th of 186 Medical Equipment stocks.
  • DYNT, NUVA, and ELMD are the stocks whose asset turnover ratios are most correlated with IRMD.

The table below shows IRMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.488 0.753 0.283
2021-03-31 0.457 0.749 0.017
2020-12-31 0.455 0.743 -0.031
2020-09-30 0.497 0.742 0.053
2020-06-30 0.545 0.753 0.144
2020-03-31 0.609 0.768 0.401

IRMD Price Target

For more insight on analysts targets of IRMD, see our IRMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $38.00 Average Broker Recommendation 1.25 (Strong Buy)

IRMD Stock Price Chart Interactive Chart >

Price chart for IRMD

IRMD Price/Volume Stats

Current price $28.55 52-week high $55.92
Prev. close $28.78 52-week low $26.00
Day low $28.40 Volume 5,365
Day high $29.00 Avg. volume 53,008
50-day MA $28.75 Dividend yield N/A
200-day MA $35.53 Market Cap 358.76M

iRadimed Corporation (IRMD) Company Bio


IRadimed Corporation manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible products in the United States and internationally. The company was founded in 1992 and is based in Winter Springs, Florida.


IRMD Latest News Stream


Event/Time News Detail
Loading, please wait...

IRMD Latest Social Stream


Loading social stream, please wait...

View Full IRMD Social Stream

Latest IRMD News From Around the Web

Below are the latest news stories about IRADIMED CORP that investors may wish to consider to help them evaluate IRMD as an investment opportunity.

Here is Why Growth Investors Should Buy iRadimed (IRMD) Now

iRadimed (IRMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Yahoo | November 29, 2022

The Zacks Analyst Blog Highlights ShockWave Medical, iRadimed and Tactile Systems Technology

ShockWave Medical, iRadimed and Tactile Systems Technology are part of the Zacks top Analyst Blog.

Yahoo | November 29, 2022

IRadimed Third Quarter 2022 Earnings: Beats Expectations

IRadimed ( NASDAQ:IRMD ) Third Quarter 2022 Results Key Financial Results Revenue: US$13.4m (up 23% from 3Q 2021). Net...

Yahoo | November 9, 2022

Investing in IRadimed (NASDAQ:IRMD) five years ago would have delivered you a 113% gain

IRadimed Corporation ( NASDAQ:IRMD ) shareholders might be concerned after seeing the share price drop 21% in the last...

Yahoo | November 7, 2022

IRadimed (IRMD) Q3 Earnings and Revenues Top Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 20.83% and 1.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 3, 2022

Read More 'IRMD' Stories Here

IRMD Price Returns

1-mo -1.04%
3-mo -14.34%
6-mo -10.42%
1-year -40.85%
3-year 24.78%
5-year 117.94%
YTD -38.22%
2021 102.68%
2020 -2.48%
2019 -4.42%
2018 61.45%
2017 36.49%

Continue Researching IRMD

Want to see what other sources are saying about Iradimed Corp's financials and stock price? Try the links below:

Iradimed Corp (IRMD) Stock Price | Nasdaq
Iradimed Corp (IRMD) Stock Quote, History and News - Yahoo Finance
Iradimed Corp (IRMD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7198 seconds.